​    January 25, 2016.  Applied Molecular  

     Transport to participate on expert panel at    
     ADVANCES IN BIOLOGICS DEVELOPMENT
     AND DELIVERY symposium in San 
     Francisco at UCSF Genentech Hall on

     March 24, 2016 

​​​Applied Molecular Transport is developing a transformative pipeline of oral and targeted biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core therapeutic areas of focus are Autoimmune Diseases & Inflammation, and Metabolic Diseases & Diabetes.

​​Applied Molecular Transport is developing a transformative pipeline of oral biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core focus is in the areas of immune-mediated inflammation and metabolic diseases.

Our microbe-inspired protein scaffolding platform is enabling the rapid engineering and validation of next-generation biopharmaceuticals with superior pharmacological properties, without the need for injection.

Our microbe-inspired protein scaffolding, cellular translocation and targeting platform is enabling next-generation biopharmaceuticals with superior pharmacological properties and enhanced safety profiles.

Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.